Results 121 to 130 of about 3,600,316 (189)
ABSTRACT Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine carcinoma that typically arises in sun‐exposed skin of older or immunosuppressed patients. Combined or collision tumors involving MCC and other cutaneous malignancies are uncommon, and tumors exhibiting more than two distinct malignant phenotypes are exceptionally rare.
Zeinab Khalil +2 more
wiley +1 more source
This review provides an update on the epidemiology, pathogenesis, and clinical/histologic features of cutaneous leiomyosarcoma. Prognostic factors (e.g., depth of tumor involvement, grade, etc.) that can facilitate risk stratification are also discussed, as are treatment approaches for this rare malignancy.
Tejas P. Joshi +4 more
wiley +1 more source
The retinoblastoma binding protein RBP2 is an H3K4 demethylase.
Changes in histone methylation status regulate chromatin structure and DNA-dependent processes such as transcription. Recent studies indicate that, analogous to other histone modifications, histone methylation is reversible.
core +1 more source
Pengaruh Pemberian Ekstrak Jintan Hitam (Nigella Sativa) terhadap Apoptosis pada Kultur Sel Retinoblastoma Melalui Ekspresi Protein E2F1 [PDF]
Retinoblastoma merupakan kanker intraokular tersering yang terjadi pada anak. Retinoblastoma merupakan tumor neuroblastik yang diakibatkan oleh mutasi gen retinoblastoma (gen RB1) yang menyebabkan mutasi protein retinoblastoma (pRB), sehingga tidak ...
dr. Lely Retno Wulandari, Sp.M(K). +3 more
core
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study [PDF]
MYCN-amplified RB1 wild-type (MYCN amp RB1 +/+) retinoblastoma is a rare and aggressive subtype, often resistant to standard therapies. Identifying unique MRI features is crucial for diagnosing this subtype, as biopsy is not recommended. This study aimed
Robin W. Jansen +106 more
core +1 more source
Retinoblastoma: Clinical and Molecular Perspectives
Retinoblastoma is a rare eye cancer that has been fundamental to the understanding of tumorigenesis. The RB gene was the first tumor suppressor gene to be discovered, and the Rb protein is targeted for inactivation in the vast majority of human cancers ...
Harbour, J. William, J. William Harbour
core +1 more source
Retinoblastoma protein: a central processing unit
The retinoblastoma protein (pRb) is one of the key cell-cycle regulating proteins and its inactivation leads to neoplastic transformation and carcinogenesis. This protein regulates critical G1 -to-S phase transition through interaction with the E2F family of cell-cycle transcription factors repressing transcription of genes required for this cell-cycle
openaire +2 more sources
Kianianmomeni A, Nematollahi G, Hallmann A. A gender-specific retinoblastoma-related protein in Volvox carteri implies a role for the retinoblastoma protein family in sexual development. Plant Cell.
Kianianmomeni, Arash +2 more
core +1 more source
In silico identification of novel CDK4 inhibitors for retinoblastoma
Retinoblastoma is a kind of cancer that mostly affects children's eyes, and this study intends to find drugs that can suppress the protein kinase cyclin-dependent kinase 4 (CDK4).
Mukesh kumar +5 more
doaj +1 more source
Molecular basis of low-penetrance retinoblastoma
Retinoblastoma is a malignant tumor of the retina that occurs primarily in young children as a result of mutations in the retinoblastoma gene (RB), the first tumor suppressor gene to be identified.
Harbour, J W
core +1 more source

